US Patent Issued to Texas Tech University System on Dec. 9 for "Inhibition of interaction between OCT4 and MAPKAPK2 or DNA-PKcs to regulate c-MYC in cancer" (Texas Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,191, issued on Dec. 9, was assigned to Texas Tech University System (Lubbock, Texas).

"Inhibition of interaction between OCT4 and MAPKAPK2 or DNA-PKcs to regulate c-MYC in cancer" was invented by Min H. Kang (Lubbock, Texas), Sung-Jen Wei (Lubbock, Texas) and Charles P. Reynolds (Lubbock, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "Embodiments of the present disclosure pertain to methods of treating a cancer in a subject by administering to the subject a compound that inhibits interaction between octamer-binding transcription factor 4 (OCT4) and Mitogen-activated protein kinase-activated protein kinase 2 (MAPKAPK2), OCT4 and DNA-dependent pr...